Another study fails to confirm ultrasonography findings of CCSVI as the purported cause for multiple sclerosis.
Chronic cerebrospinal venous insufficiency (CCSVI) is the term applied to the controversial concept of venous blockage in multiple sclerosis (MS). Zamboni and colleagues proposed that CCSVI is the cause of MS and that it is treatable with an endovascular procedure. Investigators sought to replicate the ultrasonography findings described by Zamboni, originally reported in 2009 to be 100% sensitive and 100% specific for MS (J Neurol Sci 2009; 282:21) when two or more of five criteria are present.
Included were 206 patients with MS and 70 controls who were either healthy (11), had cerebrovascular diseases (22), or had other neurological diseases (37). MS patients included all disease subtypes (e.g., relapsing-remitting, secondary progressive). …
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)